Literature DB >> 24290664

[Requirements for quality indicators. The relevance of current developments in outcomes research for quality management].

Jochen Schmitt1, Thomas Petzold, Maria Eberlein-Gonska, Edmund A M Neugebauer.   

Abstract

The assessment of the health state in patients and changes in their health state for the purpose of diagnosis, prognosis and monitoring of treatment response plays a central role in clinical practice. Quality criteria for measurements in medicine include validity, reliability, responsiveness, interpretability, and feasibility. High-quality measurement instruments are a prerequisite for evidence-based medicine. Therefore, international outcomes research groups have developed methods for quality assurance and for the standardisation of measurement instruments. Quality indicators are instruments to measure the quality of care. Due to the increasing relevance of quality assessment for all stakeholders in healthcare and due to the political intention to draw relevant conclusions from the assessment of the quality of care, quality indicators must at least meet the same high standards that are required for clinical trial end points. However, independent researchers and clinicians do not engage in the validation and standardisation of quality indicators in Germany; currently, only the AQUA institute (as assigned by the German GBA) deals with this important issue. Current activities concerning the validation of quality indicators do not meet the requirements of evidence-based healthcare. This is a critical barrier to achieving the political goals of quality medicine. Therefore, the authors propose a multi-step, multi-professional, evidence-driven and evidence-generating consensus process on the basis of established methods of outcomes research for the advancement of quality assessment with quality indicators in Germany. All relevant stakeholders should participate in this process.
Copyright © 2013. Published by Elsevier GmbH.

Entities:  

Keywords:  Güte; Measurement; Messinstrument; Qualitätsindikator; Qualitätssicherung; Reliabilität; Validität; property; quality assurance; quality indicator; reliability; validity

Mesh:

Year:  2013        PMID: 24290664     DOI: 10.1016/j.zefq.2013.09.014

Source DB:  PubMed          Journal:  Z Evid Fortbild Qual Gesundhwes        ISSN: 1865-9217


  7 in total

1.  [Measurement of disease severity in dermatology].

Authors:  S Deckert; C Apfelbacher; J Schmitt
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

Review 2.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

Review 3.  [Objectifying results in total knee arthroplasty: Is "patient satisfaction" adequate].

Authors:  C Kopkow; J Schmitt; E Haase; T Lange; K-P Günther; J Lützner
Journal:  Orthopade       Date:  2015-04       Impact factor: 1.087

4.  [Certified clinical excellence : Suitable tool for patient recruitment?].

Authors:  B Ehrenstein; M Fleck
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

5.  [Consideration of guidelines, recommendations and quality indicators for treatment of stroke in the dataset "Emergency Department" of DIVI].

Authors:  M Kulla; M Friess; P D Schellinger; A Harth; O Busse; F Walcher; M Helm
Journal:  Nervenarzt       Date:  2015-12       Impact factor: 1.214

6.  Quality Measurement Recommendations Relevant to Clinical Guidelines in Germany and the United Kingdom: (What) Can We Learn From Each Other?

Authors:  Thomas Petzold; Stefanie Deckert; Paula R Williamson; Jochen Schmitt
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

7.  [Minimum volumes in surgical treatment of lung cancer : A survey of thoracic surgeons in Germany on the introduction of a minimum volume regulation for surgical treatment of lung cancer].

Authors:  Tobias Robold; Michael Ried; Reiner Neu; Hans-Stefan Hofmann
Journal:  Chirurg       Date:  2020-12       Impact factor: 0.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.